Recent news indicates that healthcare investors Jacob Gottlieb and Stuart Weisbrod will be sharing an office with a collaboration in the near future. The two know each other well as they have worked together in the past. The article by the Daily Forex Report gives details into the two and the newly formed alliance. Weisbrod co-founded a company named Merlin in 1998, an investment company that focuses on healthcare. Weisbrod has had prior experience with other well-known companies and has multiple degrees in different majors as he was an excellent student.
He has a PhD in Biochemistry from Princeton University, an MBA in finance from Columbia University, and a BA in Chemistry from Colgate University. As he obtained a great education, he used it to build a good team around him and one of them includes Jacob Gottlieb, who worked for him previously in the year 2000 as a portfolio manager. Gottlieb had his own successful pursuits in landing big-time clients, but despite all of the success, Merlins closed its doors. Weisbrod though opened a new healthcare investment company named Iguana Healthcare Partners, and the name symbolizes the reptile Iguana, which thrives in changing environments that can blend in.
Jacob Gottlieb took the same route and created his own brand called Visium Asset Management. Gottlieb then grew Visium to an eight billion hedge fund. However, Visium then came to an end in 2016, but scandals let to its closure with accusations of insider trading and mismarking. Evidence brought forward by an employee of the company brought about its downturn. The investigation is still ongoing. Visium agreed to shell out ten million dollars in fines and Gottlieb with the role of CEO has continued to return money to investors. Gottlieb has been cleared of any charges and was not involved in the scandals. Even with Visium, Gottlieb has another company called Altium Capital, in the pharmaceutical business that can change the industry. Now with Jacob Gottlieb and Stuart Weisbrod in the same office, there is a lot of excitement from what could come out of the partnership.